Literature DB >> 21514242

Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients.

Estelle Lowry1, Richard J Woodman2, Roy L Soiza3, Arduino A Mangoni4.   

Abstract

OBJECTIVES: The anticholinergic risk scale (ARS) score is associated with the number of anticholinergic side effects in older outpatients. We tested the hypothesis that high ARS scores are negatively associated with "global" parameters of physical function (Barthel Index, primary outcome) and predict length of stay and in-hospital mortality (secondary outcomes) in older hospitalized patients. DESIGN AND
SETTING: Prospective study in 2 acute geriatric units. PARTICIPANTS: Three hundred sixty-two consecutive patients (age 83.6 ± 6.6 years) admitted between February 1, 2010, and June 30, 2010. MEASUREMENTS: Clinical and demographic characteristics, Barthel Index, full medication exposure, and ARS score were recorded on admission. Data on length of stay and in-hospital mortality were obtained from electronic records.
RESULTS: After adjustment for age, gender, dementia, institutionalization, Charlson Comorbidity Index, admission site, and number of nonanticholinergic drugs, a unit increase in ARS score was associated with a 29% reduction in the odds of being in a higher Barthel quartile than a lower quartile (odds ratio 0.71, 95% confidence interval [CI] 0.59-0.86, P = .001). The Barthel components mostly affected were bathing (P < .001), grooming (P < .001), dressing (P < .001), transfers (P =.005), mobility (P < .001), and stairs (P < .001). Higher ARS scores predicted in-hospital mortality among patients with hyponatremia (hazard ratio [HR] 3.66, 95% CI 1.70-7.89, P = .001) but not those without hyponatremia (HR 1.04, 95% CI 0.70-1.54, P = .86). The ARS score did not significantly predict length of stay (HR 1.02, 95% CI 0.88-1.17, P = .82).
CONCLUSION: High ARS scores are negatively associated with various components of the Barthel Index and predict in-hospital mortality in the presence of hyponatremia among older patients. The ARS score may be useful in the acute setting to improve risk stratification.
Copyright © 2011 American Medical Directors Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514242     DOI: 10.1016/j.jamda.2011.03.006

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  32 in total

Review 1.  The Association Between Anticholinergic Medication Burden and Health Related Outcomes in the 'Oldest Old': A Systematic Review of the Literature.

Authors:  Karen Cardwell; Carmel M Hughes; Cristín Ryan
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923

2.  Anticholinergic Drug Use and Risk to Cognitive Performance in Older Adults with Questionable Cognitive Impairment: A Cross-Sectional Analysis.

Authors:  Sunil Swami; Ronald A Cohen; John A Kairalla; Todd M Manini
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

3.  Influences of Age, Obesity, and Adverse Drug Effects on Balance and Mobility Testing Scores in Ambulatory Older Adults.

Authors:  Eric Anson; Elizabeth Thompson; Brian L Odle; John Jeka; Zachary F Walls; Peter C Panus
Journal:  J Geriatr Phys Ther       Date:  2018 Oct/Dec       Impact factor: 3.381

4.  Central Anticholinergic Adverse Effects and Their Measurement.

Authors:  Pasi Lampela; Teemu Paajanen; Sirpa Hartikainen; Risto Huupponen
Journal:  Drugs Aging       Date:  2015-12       Impact factor: 3.923

5.  Editorial: Frailty and Polypharmacy.

Authors:  Y Rolland; J E Morley
Journal:  J Nutr Health Aging       Date:  2016       Impact factor: 4.075

6.  Anticholinergic Drug Burden Tools/Scales and Adverse Outcomes in Different Clinical Settings: A Systematic Review of Reviews.

Authors:  Tomas J Welsh; Veronika van der Wardt; Grace Ojo; Adam L Gordon; John R F Gladman
Journal:  Drugs Aging       Date:  2018-06       Impact factor: 3.923

7.  The Association Between Drug Burden Index (DBI) and Health-Related Outcomes: A Longitudinal Study of the 'Oldest Old' (LiLACS NZ).

Authors:  Karen Cardwell; Ngaire Kerse; Cristín Ryan; Ruth Teh; Simon A Moyes; Oliver Menzies; Anna Rolleston; Joanna Broad; Carmel M Hughes
Journal:  Drugs Aging       Date:  2020-03       Impact factor: 3.923

8.  Associations between different measures of anticholinergic drug exposure and Barthel Index in older hospitalized patients.

Authors:  Clare V Bostock; Roy L Soiza; Arduino A Mangoni
Journal:  Ther Adv Drug Saf       Date:  2013-12

Review 9.  Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?

Authors:  Tanja Mayer; Walter E Haefeli; Hanna M Seidling
Journal:  Eur J Clin Pharmacol       Date:  2015-09-08       Impact factor: 2.953

10.  Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle.

Authors:  Hui Sian Tay; Roy L Soiza; Arduino A Mangoni
Journal:  Ther Adv Drug Saf       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.